[ad_1]
“I think 90% of pharmaceutical spend in the UK, and I’m pretty sure it’s similar in the US, is for generics… so, you [the original inventor] may well retain market share, but the price will fall,” says Graham Cookson chief executive of the Office of Health Economics, the world’s oldest health economics research organisation.
[ad_2]
[ad_1] Something to look forward to: Night vision goggles have their uses but also many drawbacks, including their weight. A new development eliminates this cost-benefit […]
[ad_1] The competition to build the iPhone of artificial intelligence is heating up. On Tuesday, the technology startup Rabbit unveiled its contender: a small, orange, […]
[ad_1] Telegram’s cofounder Pavel Durov was arrested on Saturday night after at an airport several miles north of Paris, according to French news outlets BFMTV […]